The NYU Psilocybin Cancer Anxiety Research Study is one of several psychedelic research studies currently taking place in the United States. The study seeks to understand how an ancient medicine, psilocybin, can decrease anxiety and increase spiritual and mystical experiences in individuals living with Cancer. Bonnie was an integral part of this diverse clinical research team, participating in the only Psychedelic Psychotherapy training program in the country and acting as a study therapist in the research. The February 9, 2015 edition of The New Yorker features an outstanding article on the NYU study in the renaissance of this research - "The Trip Treatment - Research into psychedelics, shut down for decades, is now yielding exciting results." by Michael Pollan. Read it now.